title: In vitro evaluation of degradation and cytotoxicity of a novel composite as a bone substitute.
abstract: The purpose of this study was to prepare and evaluate in vitro the feasibility and cytocompatibility of a novel composite (GGT) as a large defect bone substitute. The composite is tricalcium phosphate ceramic particles combined with genipin crosslinked gelatin. After soaking the GGT composites in Ringer solutions at 37 degrees C for 7, 14, 28, 42, 56, and 84 days, the in vitro biologic degradation rate and biocompatibility were determined. Substances released from soaked GGT composites were analyzed with an ultraviolet visible light spectrophotometer. In addition, the solution soaking the GGT was co-cultured with osteoblasts to determine whether or not the released substances from GGT could facilitate the growth of bone cells. After they had been cultured for 2 days, the osteoblasts were tested for differentiation and proliferation by alkaline phosphatase (ALP) activity and a MTT assay. Results indicate that the concentration of the genipin solution is a critical factor in deciding the crosslinking degree of the GGT composite. Complete crosslinking reaction in the GGT composite occurred when 0.5 wt % of genipin had been added. Cytotoxic testing revealed that 80 ppm of the genipin in the culture medium served as the level over which cytotoxicity to osteoblasts could be produced. In addition, we found that gelatin and calcium continuously were released from the GGT composite in the soaking solution, which promoted differentiation and proliferation of the osteoblasts.
authors: Department of Radiological Technology, Chungtai Institute of Health Science and Technology, Taichung, Taiwan, Republic of China.
authors: Bai-Shuan
authors: BS
authors: Liu
authors: Chun-Hsu
authors: CH
authors: Yao
authors: Yueh-Sheng
authors: YS
authors: Chen
authors: Shan-Hui
authors: SH
authors: Hsu
mesh_terms: D000469:Alkaline Phosphatase / Q000378:metabolism; D000818:Animals; D000831:Animals, Newborn; D001672:Biocompatible Materials / Q000737:chemistry / Q000378:metabolism*; D018786:Bone Substitutes / Q000737:chemistry / Q000378:metabolism*; D002130:Calcium Phosphates / Q000737:chemistry / Q000378:metabolism*; D002455:Cell Division; D002470:Cell Survival; D002478:Cells, Cultured; D005780:Gelatin / Q000737:chemistry / Q000378:metabolism*; D057889:Iridoid Glycosides; D039823:Iridoids; D008422:Materials Testing; D015394:Molecular Structure; D010006:Osteoblasts / Q000166:cytology / Q000378:metabolism; D011714:Pyrans / Q000737:chemistry / Q000378:metabolism / Q000633:toxicity*; D051381:Rats; D017208:Rats, Wistar
chemical_list: D001672:Biocompatible Materials; D018786:Bone Substitutes; D002130:Calcium Phosphates; D057889:Iridoid Glycosides; D039823:Iridoids; D011714:Pyrans; D005780:Gelatin; C007834:genipin; D000469:Alkaline Phosphatase; C018392:tricalcium phosphate